Extracorporeal life support in pandemics
Cardiopulmonary Bypass: Advances in Extracorporeal Life Support
; : 1205-1214, 2022.
Article
in English
| Scopus | ID: covidwho-2319283
ABSTRACT
Pandemic diseases have inflicted significant morbidity and mortality on humankind throughout history, often from acute respiratory failure due to pneumonia and the acute respiratory distress syndrome (ARDS). Extracorporeal membrane oxygenation (ECMO) has been used for the management of patients with ARDS during pandemics of the 21st century, including both the influenza A (H1N1) and coronavirus disease 2019 pandemics. While ECMO has been shown to improve outcomes in ARDS, it is resource intensive. During pandemic conditions, demand for ECMO has often outnumbered access and availability. In light of such limitation, healthcare systems, medical societies, and national governments have, at times, standardized approaches to and coordinated care of patients requiring ECMO in attempts to optimize patient outcomes and access to ECMO. © 2023 Elsevier Inc. All rights reserved.
Full text:
Available
Collection:
Databases of international organizations
Database:
Scopus
Language:
English
Journal:
Cardiopulmonary Bypass: Advances in Extracorporeal Life Support
Year:
2022
Document Type:
Article
Similar
MEDLINE
...
LILACS
LIS